此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Tobacco Use in Pregnancy Intervention for Cessation (ToPIC)

2020年3月23日 更新者:Kristin Ashford
The proposed project will test the effectiveness of the novel delivery of an established tobacco cessation treatment among pregnant women in Kentucky. Tobacco use during pregnancy is one of the most modifiable risk factors associated with poor birth and maternal outcomes and yet smoking prevalence among pregnant women in Kentucky is among the highest in the county and estimated to be twice that of the national average, with no meaningful declines observed in twenty years.

研究概览

详细说明

The purpose of this pilot project is to test effectiveness of a tobacco-treatment cessation intervention (American College of Obstetricians and Gynecologists (ACOG) 5 A's) through use of a non-physician healthcare champion from within the clinic's existing infrastructure. This Tobacco use in Pregnancy Intervention for Cessation (ToPIC) will involve training the identified healthcare provider to become a Certified Tobacco Treatment Specialist (CTTS) and to administer the 5 A's to pregnant Medicaid patients receiving prenatal care through two high-volume Kentucky obstetrics clinics. This trial will provide evidence to evaluate this approach to delivering an established intervention in clinical practice.

The Investigators propose to test the effectiveness of the clinical intervention by using a two-armed cluster randomized controlled design. Eligible participants will be randomized to the intervention (ToPIC) or standard of care for smoking cessation in pregnancy. This pilot project will gather quantitative and qualitative data for a mixed-method, multi-stakeholder process evaluation of intervention training and delivery. Furthermore, the Investigators' use of Medicaid claims data to examine healthcare utilization outside of maternal and infant well-care visits will enhance understanding of the strengths and limitations of these data for future evaluations. This study has the potential to significantly impact the most vulnerable in Kentucky, where rates of tobacco use among pregnant women are among the highest in the nation.

研究类型

介入性

注册 (实际的)

66

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Kentucky
      • Lexington、Kentucky、美国、40536
        • University of Kentucky College of Nursing

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 44年 (成人)

接受健康志愿者

是的

有资格学习的性别

女性

描述

Inclusion Criteria:

  • pregnant
  • tobacco user
  • able to read and write English
  • Medicaid eligible

Exclusion Criteria:

  • male

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
有源比较器:Tobacco Treatment As Usual (TTAU)
Eligible women assigned to the control group will be informed of the risks of tobacco use and benefits of quitting using the ACOG 5A's approach by their healthcare provider.5 This standard takes approximately 5-15 minutes, and is offered at each prenatal and postpartum appointment. The study coordinator will invite participants to complete the tobacco use questionnaires (TUQ),urine cotinine validation, and Expired Air Carbon Monoxide (EACO) analysis to assess ongoing tobacco use at the designated time points.
Standard of care tobacco cessation counseling for pregnant women
实验性的:ToPIC
Eligible women assigned to the intervention will receive TTAU plus ToPIC administered by the CTTS. At least once monthly, at routinely scheduled prenatal visits or through telephone, the CTTS will provide cessation counseling. The CTTS will invite participants to complete TUQs,urine cotinine validation and EACO analysis to assess ongoing tobacco use at the designated time points.
Expanded tobacco cessation counseling for pregnant women.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Smoking cessation
大体时间:Baseline to third trimester
Change in urine cotinine level
Baseline to third trimester

次要结果测量

结果测量
措施说明
大体时间
Number of cigarettes per day
大体时间:Baseline to third trimester
Self-reported change in number of cigarettes smoked per day
Baseline to third trimester
Smoking cessation after delivery
大体时间:Prior to delivery hospitalization discharge, estimated 3 days
Self-report smoking cessation
Prior to delivery hospitalization discharge, estimated 3 days
Infant birth weight
大体时间:At time of delivery
Infant weight measured in grams
At time of delivery
Gestational age
大体时间:At time of delivery
Weeks of gestation at delivery
At time of delivery
Health care utilization outside of well-visits
大体时间:Birth to 6 months
Maternal and infant visits for non-routine healthcare
Birth to 6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Kristin Ashford、University of Kentucky

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年1月22日

初级完成 (实际的)

2019年2月15日

研究完成 (实际的)

2019年2月15日

研究注册日期

首次提交

2018年1月30日

首先提交符合 QC 标准的

2018年2月20日

首次发布 (实际的)

2018年2月22日

研究记录更新

最后更新发布 (实际的)

2020年3月25日

上次提交的符合 QC 标准的更新

2020年3月23日

最后验证

2020年3月1日

更多信息

与本研究相关的术语

其他研究编号

  • 17-0658-P3K

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅